Mercuries Life Insurance : The Board approved to capital increase of CMG INTERNATIONAL TWO CO.LTD. – Marketscreener.com

Statement

1.Name and nature of the underlying assets (if preferred shares, the terms
and conditions of issuance shall also be indicated, e.g., dividend yield,
etc.):The common shares of CMG INTERNATIONAL TWO CO.LTD.
2.Date of occurrence of the event:2022/03/10~2022/03/10
3.Amount, unit price, and total monetary amount of the transaction:112,500,000
shares;10 TWD per share;1,125,000,000 TWD
4.Trading counterparty and its relationship with the Company (if the trading
counterparty is a natural person and furthermore is not a related party of
the Company, the name of the trading counterparty is not required to be
disclosed):CMG INTERNATIONAL TWO CO.LTD. ,related party of the Company.
5.Where the trading counterparty is a related party, announcement shall also
be made of the reason for choosing the related party as trading counterparty
and the identity of the previous owner, its relationship with the Company
and the trading counterparty, and the previous date and monetary amount of
transfer:NA
6.Where an owner of the underlying assets within the past five years has
been a related party of the Company, the announcement shall also include the
date and price of acquisition and disposal by the related party, and its
relationship with the Company at the time of the transaction:NA
7.Matters related to the current disposal of creditors’ rights (including
types of collaterals of the disposed creditor’s rights; if creditor’s
rights over a related party, announcement shall be made of the name of the
related party and the book amount of the creditor’s rights, currently being
disposed of, over such related party):NA
8.Profit or loss from the disposal (not applicable in cases of acquisition
of securities) (those with deferral should provide a table explaining
recognition):NA
9.Terms of delivery or payment (including payment period and monetary
amount), restrictive covenants in the contract, and other important terms
and conditions:Payment in full
10.The manner of deciding on this transaction (such as invitation to tender,
price comparison, or price negotiation), the reference basis for the
decision on price, and the decision-making unit:Par value of common stock；
The decision-making followed the authorization procedure of the company.
11.Net worth per share of the Company’s underlying securities acquired or
disposed of:NA
12.Cumulative no.of shares held (including the current transaction), their
monetary amount, shareholding percentage, and status of any restriction of
rights (e.g., pledges), as of the present moment:Cumulative no. of shares
held:180,000,000 shares,
Monetary amount:NT$1,800,000,000,
Shareholding percentage: 45%,
Status of any restriction of rights: None
13.Current ratio of securities investment (including the current trade, as
listed in article 3 of Regulations Governing the Acquisition and Disposal of
Assets by Public Companies) to the total assets and equity attributable to
owners of the parent as shown in the most recent financial statement and
working capital as shown in the most recent financial statement as of the
present:Ratio to the total assets: 77.18%Ratio to shareholders’equity of
the parent company:2608.42%,Amount of operating capital: NA
14.Broker and broker’s fee:NA
15.Concrete purpose or use of the acquisition or disposal:Fund deployment
according to Insurance Law
16.Any dissenting opinions of directors to the present transaction:NO
17.Whether the counterparty of the current transaction is
a related party:Yes
18.Date of the board of directors resolution:2022/03/10
19.Date of ratification by supervisors or approval by
the Audit Committee:2022/03/09
20.Whether the CPA issued an unreasonable opinion regarding the current
transaction:NA
21.Name of the CPA firm:NA
22.Name of the CPA:NA
23.Practice certificate number of the CPA:NA
24.Whether the transaction involved in change of business model:No
25.Details on change of business model:NA
26.Details on transactions with the counterparty for the past year and the
expected coming year:
Transactions with the counterparty for the past one year:NO
Transactions with the counterparty for the next year: follow the investment
decision of the company.
27.Source of funds:The Company’s own fund
28.Any other matters that need to be specified:None